Background Stent implantation in coronary angioplasty has reduced the rate of restenosis, but many patients still undergo follow-up coronary angiography (CAG). The present study was a multi-center retrospective analysis of the usefulness of stress single photon emission computed tomography (SPECT) compared with follow-up CAG in stent-implanted patients who remained asymptomatic during the follow-up period.
estenosis after successful percutaneous transluminal coronary angioplasty (PTCA) remains an important clinical problem, and many patients undergo follow-up coronary angiography (CAG) at 3-6 months after PTCA. 1 Among the newly developed techniques for myocardial revascularization, the implantation of coronary stents has rapidly gained widespread clinical acceptance and the rate of restenosis (and also of revascularization) has been reduced compared with PTCA alone. [2] [3] [4] Therefore, follow-up CAG may be less beneficial, especially for asymptomatic patients.
The usefulness of perfusion scintigraphy in the follow-up of symptomatic and asymptomatic patients after PTCA has been defined by several studies, [5] [6] [7] [8] [9] [10] and because stents are usually implanted in proximal lesions of coronary arteries, and the influence of coronary spasm at the stent site has been basically excluded, the usefulness of perfusion scintigraphy for following up patients after stent implantation is expected to increase. [11] [12] [13] However, because perfusion scintigraphy has been evaluated only qualitatively or semi-quantitatively, there are intra-and inter-observer variations.
The present study was a multi-center trial to retrospectively investigate the diagnostic value of stress single photon emission computed tomography (SPECT) in comparison with follow-up CAG in patients with stent implantation who remained asymptomatic during the follow-up period.
Methods

Patient Population
In the 5 collaborating hospitals, 114 patients underwent both stress SPECT and CAG at 4-9 months after successful stent implantation between February, 1997 and April, 2000. Eleven patients who complained of chest pain during the follow-up period were excluded from the analysis. Because stents had been implanted in 2 different vascular territories in 3 patients, 106 vascular territories in 103 patients (76 males, 27 females; 40-86 years of age) were available for evaluation. Table 1 summarizes the characteristics of the patient population. The mean interval between stent implantation and stress SPECT was 176±31 days (range, 120-266 days); 55 of 106 lesions (52 %) were related to a prior myocardial infarction (MI).
Stent Placement
Stent types included 61 tube and 54 coiled stents (11% Palmatz-Schatz, 28% Multilink, 13% Nir, 2% Wiktor, 9% GRII, 37% GFX, 1% S670). Stents were implanted electively in 33 territories for stable angina and as emergencies in 73 territories for acute coronary syndrome (27 for unstable angina pectoris and 46 for acute MI). The mean stenosis was 94.5±7.1% before and 4.6±11.9% after stent implantation by quantitative coronary analysis.
CAG
All the patients underwent follow-up CAG 130-267 days after stent implantation (Table 1) . Coronary artery stenosis was assessed by at least 2 cardiologists without knowledge of the SPECT results. Stent restenosis was defined by quantitative coronary analysis as a >50% luminal narrowing at the implantation site or at the proximal or distal edges.
Stress Scintigraphy Protocols
Of 103 patients, 96 underwent symptom-limited exercise testing using a bicycle ergometer or treadmill exercise under the standard Bruce protocol while fasting. In 7 patients who were unable to exercise, dipyridamole stress tests were performed using a 4-min infusion of 0.56 mg/kg per min dipyridamole. All tests were performed mid-morning, and cardiac medications were withheld on the morning of the day of testing. For all stress protocols, patients were continuously monitored with 12-lead electrocardiogram (ECG). Indications for stopping the exercise test were uncomfortable dyspnea or angina, serious arrhythmias, progressive reduction of systolic blood pressure, significant ST change and target heart rates. Either 1 min before the anticipated end of exercise or 3 min after the end of the dipyridamole infusion, 74 mBq 201 Tl (for 65 patients), 5× 37 mBq 99m Tc-tetrofosmin (32 patients) or 99m Tc-sestamibi (6 patients) (Nihon Mediphysic Inc and Daiichi Inc, Japan) was injected intravenously and flushed with saline, and the patient was encouraged to exercise for an additional minute. Early SPECT was performed 5-10 min after exercise and late SPECT was performed 3-4 h after early SPECT. The 15×37 mBq 99m Tc-tetrofosmin or 99m Tcsestamibi was reinjected when late SPECT was performed. The SPECT images were acquired using a 2-or 3-headed SPECT system. 14 Transverse slices were reconstructed by a filtered backprojection algorithm after pre-processing of the images with Butterworth low-pass filter. Vertical longaxis, short-axis, and horizontal long-axis tomograms were reconstructed from the transverse slices.
Visual Analysis of the SPECT Images
The uptake score of perfusion imaging was visually determined for each of the total 9 myocardial segments (basal anterior, basal septum, basal inferior, basal lateral, apical anterior, apical septal, apical inferior, apical lateral walls and apex) according to a 4-point scoring system: 3= normal, 2= mildly reduced, 1= moderately reduced and 0= markedly reduced (Fig 1) . We considered a scan was positive for ischemia when there was a reversible defect in at least one adjacent segment in the territory referable to the vessel treated by stents (I1, I2 for the right coronary artery, A1, A2, S1, S2, Ap for the left anterior descending artery, and L1, L2 for the left circumflex artery). 15, 16 For the purposes of visual interpretation, stress and rest tomograms were evaluated by consensus of 2 observers.
Data Analysis
Data are expressed as means ± standard deviation (SD). The sensitivity of SPECT imaging was defined as the number of true-positive test results divided by the sum of the true-positive and false-negative test results. The specificity was defined as the number of true-negative test results divided by the sum of the true-negative and false-positive test results. The positive predictive value was defined as the number of true-positive test results divided by all the positive test results. The negative predictive value was defined as the number of true-negative test results divided by all the negative test results. Accuracy was defined as the number of true-positive and true-negative test results divided by the total number of tests. Categorical variables were compared among the groups of patients by chi-square analyses. Table 2 shows the results of CAG and SPECT imaging in all territories. Twenty of 106 (19%) investigated coronary arteries showed >50% stenosis at the site of stent implantation in the follow-up CAG. A reversible perfusion defect was found in 32 of 106 (30%) vessel territories and angiographic restenosis was present in 13 of these territories. In contrast, restenosis was found in only 7 of 74 territories that did not show a reversible perfusion defect.
Results
SPECT Defect and CAG Restenosis
Diagnostic Performance of SPECT
The diagnostic performance of SPECT imaging for predicting angiographic restenosis is shown in Table 3 . The sensitivity and specificity of SPECT imaging were 65% and 78%, respectively, the positive and negative predictive values were 41% and 91%, and the accuracy was 76%. The sensitivity, specificity and accuracy of exercise ECG testing (103 cases) were 25%, 74% and 64%, respectively. Table 3 also shows the performance of SPECT imaging for predicting angiographic restenosis in subpopulations of vessel territories with regard to the presence of a prior MI, the number of diseased vessels, and the site of the lesion. There were no significant differences among the groups, but the accuracy tended to be lower if there was a prior MI, three-vessel disease or the lesion was in the left circumflex artery.
Prevalence of False-Negative Cases
Because the present study was designed to examine the usefulness of SPECT imaging in determining the necessity for CAG in patients who remained asymptomatic during the follow-up period after stent implantation, the causes of negative SPECT results in cases with angiographic restenoses (ie, false-negative cases) are important. Fig 2 shows the negative predictive values in all and the subpopulations of the vessel territories. The values did not differ significantly, but tended to be lower for three-vessel disease and lesions in the left circumflex artery. Table 4 summarizes the characteristics of the 7 false negative cases, which included 4 cases with a prior MI for the stentimplanted vessel, and 2 cases with reversible ischemia in other vessel territories. In 2 cases, the exercise tolerance was insufficient (<80% of target heart rate), although 1 case underwent dipyridamole infusion. Table 1 for other abbreviations).
Discussion
This multi-center trial was designed to retrospectively examine the usefulness of SPECT imaging for determining the necessity of CAG in patients with stent implantation who remained asymptomatic during the follow-up period. The study population was not homogeneous in terms of the type of stress, tracer, scintigraphic modalities, and time interval between SPECT and CAG. Nevertheless, the present results indicate that SPECT imaging has a good noninvasive diagnostic performance in the follow-up evaluation of patients after coronary stent implantation.
Comparison With Previous Studies
Because restenosis is the prime limitation of PTCA, many cardiologists perform functional testing 3-6 months later, even in asymptomatic patients. Garzon and Eisenberg reviewed the diagnostic ability of exercise tolerance testing (ETT), stress nuclear imaging and stress echocardiographic imaging to detect post-PTCA restenosis in 36 previous studies and found that ETT alone was poorly diagnostic, but that the addition of nuclear imaging significantly improved the diagnosis of restenosis. 17 In their analyses, stress nuclear imaging had a sensitivity of 87% (74-100%) and a specificity of 78% (74-81%). [5] [6] [7] [8] [9] [10] Three recent studies have shown similar values for sensitivity (79-95%) and specificity (73-84%) for stent restenosis. [11] [12] [13] There are several potential explanations for the finding of a high sensitivity of SPECT imaging to detect restenosis of stent-implanted vessels. First, stents tend to be placed in large vessels and frequently in the proximal segments. Therefore, in the presence of restenosis involving the stent itself, the altered flow reserve would involve a large area of myocardium and would be easily detectable by perfusion imaging. Second, recent histological and intravascular ultrasound investigations have suggested that the major determinant of late lumen loss and in-stent restenosis is neointimal tissue proliferation. 18 Because the recoil and spasm of the stentimplanted lesion could in principle be excluded, the followup testing can be performed at the most appropriate time interval (3-6 months) to identify patients with restenosis. Furthermore, most patients can undergo maximum exercise testing without or with minimal dosages of anti-anginal drugs.
We identified a sensitivity of 65% and a specificity of 78% for the detection of angiographic restenosis by SPECT imaging. Because the sensitivity and specificity of exercise ECG testing were 25% and 74%, SPECT imaging largely improved the diagnostic ability for detecting stent restenosis. However, the values we obtained were slightly lower than those in the other studies, for the following reasons. First, many of the previous studies had patient populations with a high prevalence of restenosis or a low prevalence of either multi-vessel disease or previous MI. [8] [9] [10] The present cases were asymptomatic with a much lower rate of restenosis (19%) than those observed in earlier studies, and included more cases of multi-vessel disease (41%) and prior MI (52%). It is noteworthy that patients with a low probability of restenosis would have a substantially high negative predictive value with SPECT imaging. Therefore, it is likely that a negative SPECT result is clinically useful in patients with a low pre-test probability of restenosis. From that viewpoint, the high negative predictive value in this study (~90%) suggests that a negative test result may be indicative of a good prognosis. [19] [20] [21] Second, some previous studies defined abnormal uptake as a positive SPECT result, whereas we used the defect reversibility criterion, which might result in a lower sensitivity of SPECT imaging to identify angiographic restenosis while retaining a high specificity.
Characteristics of False-Negative Territories
Previous studies have demonstrated lower sensitivity and specificity values in territories with a prior MI, 12, 22 and the scintigraphic evaluation of stent restenosis in such cases is limited because of the pre-existing perfusion abnormalities. In the analysis by Kosa et al of SPECT imaging, the sensitivity and specificity were only 64% and 78%, respectively, 12 whereas on the present study the overall accuracy of SPECT was 71% in territories with prior MI (vs 80% in no prior MI) and the 4 territories with prior MI were false negatives. Stress-induced ischemia in other territories could also disturb the diagnostic performance of SPECT; in this study, both the negative predictive value and overall accuracy in three-vessel disease were lower than in one-or two-vessel disease. Furthermore, 2 territories were false negative because of ischemia in other territories. In these cases, however, the angiographic stenoses were between 50% and 75%. The appropriate choice of the cutoff for significant restenosis should be considered. 10, 23 In addition, one territory with stent restenosis was missed, presumably because of insufficient exercise loading (62% of target heart rate). Patients who have insufficient exercise tolerance should undergo pharmacological stress for a more accurate result. Therefore, although our results indicated the usefulness of SPECT imaging as the follow-up of asymptomatic patients after coronary stent implantation, the interpretation of SPECT results should be made carefully, especially in cases of prior MI for the stent-implanted vessel, three-vessel disease, or insufficient stress loading.
In conclusion, stress SPECT imaging is a useful tool for following up patients after coronary stent implantation, and the follow-up CAG could be omitted for those with negative SPECT imaging, no prior MI in the stent-implanted vessel, one-or two-vessel disease, and sufficient stress loading. The best strategy for the follow-up of patients who have undergone coronary stent implantation in terms of accuracy, patient morbidity, and cost has yet to be determined. If our results can be confirmed in future prospective evaluations, SPECT imaging may be a useful strategy to diagnose or exclude restenosis and therefore may avoid the need for follow-up CAG in patients without or with minimal symptoms after coronary stent implantation. For this purpose, the appropriate time interval between stent implantation and stress SPECT imaging should be determined, and the influence of lesion morphology, length, and site of restenosis (eg, in-stent, proximal or distal edge of stent) on the diagnostic performance of SPECT should be examined further.
